Bulldog Bio Purchases All Assets from Bridge Bioscience
Bridge Bioscience Inc. has completed the transfer of all assets and intellectual property associated with the business to Bulldog Bio Incorporated. Bridge Bioscience has been manufacturing and providing high quality electroporation cuvettes for over eight years. These disposables are used for the delivery of DNA and RNA into a variety of eukaryotic and prokaryotic cells. With this purchase Bulldog Bio will complement their existing lines of transfection products and establish a manufacturing base for the company.
Ella Fontaine, Vice President of Communications at Bulldog Bio stated “The business model developed by Bridge of offering direct from manufacturer pricing, will allow Bulldog Bio to continue to provide these quality products at a very affordable level.” She further remarked “Bridge Bioscience has always run as a profitable business and it is our intent to maintain the current sales channel. We will look to develop growth in new markets in which the Bridge Electroporation Cuvettes are currently not being sold.”